261 related articles for article (PubMed ID: 32432743)
1. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
Zheng TL; Cen K
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
3. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
Cui SH; Hu XD; Yan Y
J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.
Zhang ZC; Liu JX; Shao ZW; Pu FF; Wang BC; Wu Q; Zhang YK; Zeng XL; Guo XD; Yang SH; He TC
Medicine (Baltimore); 2017 Jul; 96(27):e7245. PubMed ID: 28682874
[TBL] [Abstract][Full Text] [Related]
5. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
Guo J; Wen N; Yang S; Guan X; Cang S
Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
[TBL] [Abstract][Full Text] [Related]
6. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
7. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
9. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
[TBL] [Abstract][Full Text] [Related]
10. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract][Full Text] [Related]
11. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
Yang K; Zhao J; Liu S; Man S
Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
[TBL] [Abstract][Full Text] [Related]
13. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation.
Liu HR; Zhao J
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897
[TBL] [Abstract][Full Text] [Related]
14. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-92a-2-5p potentially contribute to anorectal malformations by inhibiting proliferation and enhancing apoptosis via PRKCA/β-catenin.
Long CY; Xiao YX; Li SY; Tang XB; Yuan ZW; Bai YZ
Biomed Pharmacother; 2020 Jul; 127():110117. PubMed ID: 32244197
[TBL] [Abstract][Full Text] [Related]
16. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
[TBL] [Abstract][Full Text] [Related]
17. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
[TBL] [Abstract][Full Text] [Related]
18. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
